血管紧张素转换酶抑制剂的抗动脉硬化作用及研究进展
Progress of antiatherosclerotic effects for angiotensin converting enzyme inhibitors(ACEI)
出处
《老年医学与保健》
CAS
2001年第1期60-62,共3页
Geriatrics & Health Care
参考文献20
-
1Scicli AG. Increases in cardiac kinins as a new mechanism to protect the heart. Hypertension, 1994, 23:419 ～ 21.
-
2Farhy RD, Carretero OA, Ho KL, et al. Role of kinins and nitric oxide in the effectd of angiotensin converting enzyme inhibitors on neointima formation. Circ Res, 1993, 72:1202 ～ 10.
-
3Losito A, Gaburri M, Errico R, et al. Survival of patients with renovascular disease and ACE inhibition. Clin Nephrol, 1999, 52(6): 339 ～ 343.
-
4Stefikova K, Spustova V, Gazdikova K, et al. Dietary protein restriction in combination with angiogensin converting enzyme inhibitor improves insulin resistance in patients with chronic renal disease. Int Urol Nephrol,1997, 29 (4): 497 ～ 507.
-
5Ludwig EH, Boricki IB, Ellison RC, et al. Associations between candidate loci angiotensin- converting enzyme and angiotensinogen with coronary heart disease and myocardial infarction: NHLBI Family Heart Study. Ann Epidemiol 1997, 7(1): 3 ～ 12.
-
6Lacourciere Y, Gagne C. Influence of combination of captopril and hydrochlorothiazide on plasma lipids, lipoproteins and apolipoproteins in primary hypertension. J Hum Hypertens, 1993, 7:149 ～ 152.
-
7Does the new angiotensin converting enzyme inhibitar Cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty, Results of the MERCATOR study: A multicenter European Research Trial with Cilazapril after Angioplasty to prevent Transluminal Coronary Obstruction and Restenosis (MERCATOR) study Group [comment]. Circulation,1992, 86(1): 100 ～ 110,
-
8Berger PB, Holmes DR Jr, Ohman EM, et al. Restenosis, reocclusion and adverse cardiovascular events after successful balloon angioplasty of occluded versus nonoccluded coronary arteries. Results from the multicenter American Research Trial with Cilazapril After Angioplasty to prevent Transluminal coronary obstruction and Restenosis (MARCATOR).J Am Coll Cardiol, 1996,27(1): 1 ～7.
-
9Gurzen NP, Fox KM. Do ACE Inhibitors modulate atherosclerosis? Eur Heart J, 1997, 18(10): 1530 - 1535.
-
10SOLVD Investigators, Effect of enalapril on survival in patients with re duced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991, 325:293 ～ 302.
-
1王玉倩,葛久欣,吴爱丽,姜春艳,刘雨晶.瑞舒伐他汀治疗高血压骨质疏松症患者的研究[J].黑龙江医学,2013,37(4):271-272.
-
2孙丽霞.低分子肝素联合阿托伐他汀钙治疗合并糖尿病的不稳定性心绞痛疗效观察[J].现代医药卫生,2010,26(5):742-743. 被引量：2
-
3闫胜敏,李拥军.原发性高血压与脂联素、C反应蛋白关系及机制的研究进展[J].临床合理用药杂志,2011,4(7):145-146. 被引量：5
-
4任忠法,薛现中,官庆波.2型糖尿病患者抗动脉粥样硬化的临床研究进展[J].医学综述,2009,15(11):1696-1698. 被引量：5
-
5杨阳,李平.三七粉对原发性高血压病患者的疗效观察[J].中医临床研究,2017,9(3):29-30. 被引量：8
-
6滕雅秋,林旭荣.急性冠脉综合征患者CRP、IL-6的变化及阿托伐他汀钙对其影响[J].中国实用医药,2011,6(12):168-169.
-
7张蕾,刘润华.糖尿病合并心血管疾病的防治[J].中国现代医药,2005,4(2):19-20.
-
8秦明照,王国宏.美国心脏协会关于糖尿病合并心血管疾病的防治报告[J].中国医药导刊,2002,4(1):4-7. 被引量：2
-
9韩巧君.关注糖尿病性心脏病[J].糖尿病新世界,2010(11):22-22. 被引量：1
-
10Gree.,P.心血管医学的未来对预防和康复是种机遇[J].国外学者来访报告,1997,17(4):26-30.
